Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-24

Clinical Trial Update: Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating the effects of mifepristone on stress sensitivity and relapse prevention in cocaine-dependent patients has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mifepristone (mifepristone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Cocaine Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-08-24